Utility of in vitro release testing (IVRT) to assess ‘sameness’ of 1

AAPS Open(2023)

引用 0|浏览0
暂无评分
摘要
The October 2022 draft United States Food and Drug Administration (FDA) guidance presents an option of in vitro release test (IVRT) studies as a biowaiver for topical drug products submitted in abbreviated new drug applications (ANDAs). However, the product-specific guidance (PSG) for 1
更多
查看译文
关键词
In vitro release testing (IVRT),Sameness,Pharmaceutical equivalence,Biowaivers,Topical clotrimazole creams
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要